Wang W, Wu G, Luo W, Lin L, et al. Anlotinib plus oral fluoropyrimidine S-1 in refractory or relapsed small-cell lung cancer (SALTER TRIAL): a multicenter, single-arm, phase II trial. BMC Cancer 2024;24:1182.
PMID: 39333988